A s bstract. We examined the effect of bovine aortic endothelial cell culture supernatants upon the generation of procoagulant activity by human blood monocytes. Confluent endothelial monolayers were cultured for up to 96 h. At timed intervals, culture supernatants were collected and incubated for 5 h with lipopolysaccharide-stimulated human peripheral blood mononuclear cells. The procoagulant activity of mononuclear cell lysates was determined in a one-stage clotting assay. In five experiments, procoagulant activity with culture supernatant (time 0) was 2,294±761 U/ml (mean±SEM). Culture supernatants from endothelial cells incubated for 24-96 h strongly inhibited mononuclear cell generation of procoagulant activity. Indomethacin (10 ,uM) added to endothelial cells delayed the appearance of procoagulant inhibitor for 72 h. Bovine aortic smooth muscle cell culture supernatants did not inhibit procoagulant activity. The inhibitor was heat stable, effective at 1:50 dilution, soluble, and acid sensitive, with a molecular weight of <1,500. Further studies on subpopulations of mononuclear cells demonstrated that endothelial inhibitor selectively decreased the generation of monocyte procoagulant activity and interfered with T lymphocyte amplification of monocyte production of procoagulant activity. Thus, we have demonstrated that endothelial cells elaborate a potent inhibitor of monocyte procoagulant activity.
Introduction
Vascular endothelial cells have important interactions with components of blood coagulation. They synthesize prostacyclin, which inhibits platelet aggregation (1) . They also synthesize and secrete a plasminogen activator (PA)' (2) which may contribute to the dissolution of fibrin clots in the vascular lumen. Endothelial cells are thought to be the primary source of the high molecular weight subcomponent of human antihemophilic factor (Factor VIII-related antigen) (3) and have been shown to have some thromboplastic activity (4). They also have receptors for thrombin (5) that may play a role in the activation of protein C (6) .
Increasing evidence suggests that peripheral blood monocytes (PBMs) also may be important in blood coagulation. PBMs synthesize PA (7) . They have been shown to have receptors for thrombin binding (8) ; as precursors of the reticuloendothelial system they may thus have an important role in clearing activated components ofthe coagulation cascade. In addition, PBMs generate procoagulant activity (PCA), identified as tissue factor, and can activate, in vitro, the extrinsic blood coagulation pathway (9) .
More recently, investigators have shown that PBMs have important interactions with vascular endothelial cells. PBMs secrete a monocyte growth factor that affects human vascular cell proliferation (10) . Fc-dependent binding of PBMs occurs in areas of endothelial injury (1 1). These observations link circulating PBMs with the injury-repair cycle believed to be important in atherogenesis (12, 13) .
In this report, we present evidence that bovine aortic endothelial cells (BAEs) elaborate an inhibitor of the generation of human blood monocyte PCA.
Methods

Cell cultures
BAEs. Endothelial cells from adult bovine aortae were isolated according to previously described methods with minor modifications (14, 15) . Thoracic aortic segments, 15 to 20 cm long, were dissected free of adventitial fat, intercostal branches were ligated, and one end was tied offwith umbilical tape. The aortae were rinsed three times with Dulbecco's phosphate buffered saline (PBS) to remove blood and were refilled with a solution of collagenase (1 mg/ml; type I; Worthington Biochemical Corp., Freehold, NJ) in Hanks' balanced salt solution. The upper ends of the vessels were tied off and incubated at 370C for 15-20 min. After incubation, the collagenase solution was saved and each vessel was refilled and rinsed three times with Dulbecco's modified Eagle's medium (DMEM; Gibco Laboratories, Grand Island, NY) supplemented with 20% heat-inactivated (560C, 30 min) fetal bovine serum (FBS; KC Biological, Lenexa, KS).
Cells from the collagenase digest and washings were pooled, centrifuged, and resuspended in fresh DMEM with 20% FBS, and plated into T-75 flasks (Costar Corp., Cambridge, MA). In these experiments, confluent BAEs were subcultured from the flasks into 35-mm petri dishes (Coming Glass Works, Coming, NY) by brief trypsinization (1 mg/ml trypsin) (type TRL; Worthington Biochemical Corp.). Cells were seeded at a density of 2 X 10 cells per dish in 2 ml of DMEM with 20% FBS. After 24 h, cell cultures were refed with fresh medium. After an additional 72 h to allow cells to reach confluence, the media from confluent cultures were removed and the monolayers were rinsed with Dulbecco's PBS. At time 0, 2 ml of DMEM with 10% FBS was added to each dish with or without the indicated concentration of indomethacin (Sigma Chemical Co., St. Louis, MO). At timed intervals thereafter, conditioned culture medium (Cm) from individual dishes was aspirated and stored in duplicate at -70'C for later testing. The corresponding cell culture monolayers were counted on a cell counter (Coulter Electronics, Inc., Hialeah, FL). BAEs underwent 5-12 serial passages during our experiments. Cells were >99% viable as tested by the trypan blue dye exclusion test and were also positive for antihemophilic factorrelated antigen (15) . The morphologic appearance of confluent vascular endothelial cells used in these experiments is seen in Figure 1 A.
Bovine aortic smooth muscle cells (SMCs). SMCs were obtained by use ofthe same aortic segments from which endothelial cells were derived, as described above. Briefly, after collagenase treatment to remove endothelium, segments of intima and media were removed by dissection and minced into -1-mm squares. The explants were implanted between two coverslips (envelope technique) as previously described (16) . The coverslips were placed into Leighton tubes and each tube was filled with 1.5 ml of DMEM plus 10% FBS and refed every 3-4 d. When solid outgrowth around the explants was obtained (usually 2-3 wk), the coverslips were separated, the explants were removed, and the cells were removed by trypsinization. SMCs were routinely cultured in DMEM plus 10% FBS in T-75 flasks.
In these experiments, SMCs were used for between 2-8 passages. Cells were subcultured into 35-mm dishes with DMEM plus 10% FBS. The experimental conditions for SMCs were the same as described above for BAEs. The morphology of confluent bovine vascular SMCs used in these experiments is seen in Figure 1 (18, 19) . PBMCs were disrupted by repeated (three times) freezethaw cycles. Equal volumes (0.1 ml) of cell lysate, prewarmed pooled human plasma, and 0.025 M CaCl2 were then mixed and the clotting time was recorded. PCA units were calibrated from rabbit brain thromboplastin (Difco Laboratories Inc., Detroit, MI), 36 mg in 1.0 ml H20, arbitrarily assigned a value of 100,000 U/ml (19); a double logarithm plot of clotting time versus thromboplastin concentration generated a straight line to a 105 dilution of the standard. Serial dilutions of PBMC suspensions generated a line whose slope was identical to that of the standard curve. The assay was Factor VII-dependent (loss of 95% activity when Factor VII-deficient plasma was substituted for pooled human plasma) and diisophosphofluorate resistant. Activity was expressed as the mean of duplicate values.
PA assay. PA of confluent monolayers of BAEs was assayed by a modification of a previously described amidolytic technique (20) . After removal of Cm, monolayers adherent to 35-mm petri dishes were washed three times with phosphate-buffered saline, detached, and extracted with 0.1 % Triton X-I 00 in H20, and the extract (0.5 ml) was frozen at -70'C until assay. All assays in an experiment were performed on either fresh or once-thawed samples. Plasminogen dependence of the enzymatic activity was assured by concomitant assay of identical sample aliquots in the absence of plasminogen, which uniformly generated no plasminlike amidolytic activity. Samples were assayed either undiluted or at a dilution demonstrating plasmin activity, which could be plotted on a linear curve obtained with serial dilutions of urokinase (CalbiochemBehring Corp., American Hoechst Corp., San Diego, CA) in the same assay system. Results are recorded in PA units (arbitrary units relative to urokinase)/2 X 105 cells.
Column chromatography. Sephadex GI5 (Pharmacia Fine Chemicals Inc., Piscataway, NJ) was swollen in RPMI (Gibco Laboratories) containing 50 U/ml penicillin and 50 tug/ml streptomycin (Gibco Laboratories). The gel was packed in a 1.5 cm X 50 cm column and run at 30 cm pressure. 30 ml RPMI containing 2 mg/ml blue dextran and 1 M NaCl was used to calibrate the column. 2.5 ml BAE culture media (96 h) was applied to the column, which was then eluted with RPMI in 1.8-ml eluate fractions.
Statistics. Data were analyzed by the t test for tests of significant differences unless otherwise stated. Data for Fig. 3 were subjected to analysis of variance and covariance with repeated measures (BMDP2V, University of California, Los Angeles) with one grouping factor (cell group) and one within factor (culture time). Data in Table V were analyzed using the paired t test.
Results
In five experiments, cultured BAEs elaborated an inhibitor of human PBMC procoagulant activity (Fig. 2) . PBMC had a base- CULTURE TIME (h) Figure 2 . Effect of BAE culture medium on PBMC procoagulant activity. Aliquots of medium from BAE incubated for various time intervals (abscissa) were cocultured with LPS-stimulated PBMCs (solid line). The generation of PCA by PBMCs was determined in a onestage clotting assay and converted to units per milliliter from a standard curve using rabbit brain thromboplastin (ordinate). (Fig. 2) . Simultaneous cell counts of cultured BAEs showed only a slowly increasing number of viable cells throughout the incubation period (1.4 X 106/dish at time 0 to 2.6 X 106/dish at 96 h). Control experiments showed that Cm added to PBMCs after a 5-h incubation in the presence of LPS (10 ,ug/ml) did not block the expression of PCA in our clotting assay. Similarly, Cm did not block the expression of PCA by rabbit brain thromboplastin.
Parallel experiments demonstrated that bovine SMC culture supernatants did not inhibit PBMC procoagulant activity generation, nor did culture supernatants from control wells without cells that were incubated at 37°C and 5% CO2 (Fig. 3) .
Serial dilution of Cm (96 h) with DMEM plus 10% FBS before coculture with PBMCs resulted in increasing generation of PCA. Dilutions ofCm as much as 1:50 generated a line whose slope paralleled the line obtained by serial dilutions of rabbit brain thromboplastin (Fig. 4) , demonstrating the potency ofthe inhibitor and excluding the possibility that BAEs simply depleted Cm of critical nutrients required for the generation of PCA.
The effects of freeze-thawing, storage at -70°C, incubation at increasing temperatures, and acidification-neutralization were investigated (Table I ). The inhibitor was stable to freeze-thawing and short-term storage at -70°C but lost -25% activity upon storage for up to 120 d or incubation at various temperatures. Complete loss of inhibitory activity was seen with acidificationneutralization.
To determine if the inhibitor was soluble or membraneassociated, BAE culture medium (72 h) was separated into supernatant and precipitate by ultracentrifugation at 150,000 g for 30 min at 40C. Each fraction was then co-incubated with PBMCs in the presence of LPS, 10 ,ug/ml, for 6 h, and the in response to LPS, immune complexes, or very low density lipoprotein is augmented by collaborative interaction with T lymphocytes present in cell cultures (19). Thus, the decreased PCA generated by LPS-stimulated PBMC cultured in BAE culture media could reflect a direct inhibition ofmonocyte synthetic function or result from decreased T cell amplification. To distinguish between these possibilities, purified PBM and T lymphocyte fractions were prepared, and the effects of Cm on PCA generation and T lymphocyte collaboration were examined (Table III). In these studies, Cm decreased by 60% the LPS-stimulated PCA of PBMs cultured alone and by 71% the PCA of PBMs cultured with T lymphocytes. When PBMs were incubated with Cm for 2 h, washed, and added to T lymphocytes, the To determine the approximate molecular weight of BAE inhibitor, BAE culture media was subjected to Sephadex G-1 5 chromatography (Fig. 5) . Elution fractions were cocultured with PBMCs (see Methods), and the effect on the generation of PCA by PBMC was assayed. Inhibition ofPBMC procoagulant activity was detected in the elution fraction just before the elution of NaCl, confirming that the inhibitor is of very low molecular weight.
BAEs are known to produce and secrete PA (2, 20) . It has been previously demonstrated that the introduction of fresh serum-containing media on confluent endothelial cells suppresses the secretion of plasminogen activator (21) . PA secretion by BAE recovers 72-96 h after exposure to fresh serum-containing media. Therefore, assays for BAE procoagulant inhibitor and PA were performed to see iftheir elaboration occurred in parallel in BAE cultures that had been washed and refed with DMEM plus 10% FBS. At Figure 5 . Elution of bovine endothelial cell inhibitor to human PBMC procoagulant activity. Elution fractions from the column (abscissa) were cocultured with PBMCs. The effect on the generation of PCA is shown on the ordinate. Void volume of the column is marked with blue dextran and represents molecules of molecular weight >1,500. The inhibitor was detected in the elution fraction just before the elution of NaCI, confirming that the inhibitor is of very low molecular weight. 
Discussion
PBMs have been shown to participate in the cellular initiation of coagulation and the generation of fibrin (22) . In vitro, monocytes can generate procoagulant material (tissue factor) and thus activate the extrinsic pathway, after stimulation by endotoxin, mitogens, antigens, immune complexes, or activated complement (23, 24) . Monocyte tissue factor is also felt to play a role in the immune response (25) , in that impaired mononuclear cell tissue factor generation has been observed in patients with immunodeficiency (26). In vitro leukocyte PCA has been correlated with clinical delayed hypersensitivity reactions (27) . The generation of PCA by monocytes is induced (28) and supported (19, 29) by their interaction with T lymphocytes, thus providing a further link to the immune response. On the basis of these studies, there is ample evidence that monocytes play an integral part in the expression of cellular immunity and blood coagulation. Previous investigations have indicated that vascular endothelial cells have important interactions with components of blood coagulation (1-6). There is also evidence that vascular endothelial cells play a role in the initiation ofimmune responses. Recent studies have shown that human endothelial cells have antigen-presenting properties (30) and can function as accessory cells for mitogen-induced T lymphocyte activation (31) .
In addition to the growing evidence cited above for interactions between circulating monocytes, lymphocytes, and vascular endothelial cells 
